INFIQ — Infinity Pharmaceuticals Share News
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
- $0.00m
- -$17.75m
- $2.59m
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX
U.S. STOCKS ON THE MOVE-PaxMedica, Heron, Belite Bio
Brief: Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma
Infinity Pharma falls after termination of merger with MEI Pharma
Brief: Infinity Pharmaceuticals Announces Stockholder Approval Of Merger With Mei Pharma
Brief: MEI Pharma Provides Final Reminder To Shareholders To Vote For Merger With Infinity Pharmaceuticals
Brief: Infinity Pharmaceuticals Inc - Glass Lewis And Iss Recommend That Stockholders Of Infinity And Mei Vote For Merger Between Two Companies
Brief: ISS Recommends Infinity Pharmaceuticals Stockholders Vote For The Merger With MEI Pharma Inc
Brief: Infinity Pharmaceuticals Says On June 27, Got Letter From Nasdaq Determining To Delist Co’S Common Stock From Nasdaq
Brief: Anson Funds And Cable Car Capital Issue Statement Regarding Proposed Transaction Between Mei Pharma And Infinity Pharmaceuticals
Infinity Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview
Infinity Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Infinity Pharmaceuticals Inc Says On April 4, Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Infinity Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Infinity Pharmaceuticals Posts FY Loss Of $0.50 Per Share
Infinity Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview